Aemetis (NASDAQ:AMTX) Upgraded at StockNews.com

StockNews.com upgraded shares of Aemetis (NASDAQ:AMTX) to a sell rating in a report issued on Friday.

Separately, HC Wainwright reissued a “buy” rating and issued a $28.00 price target on shares of Aemetis in a research report on Monday, December 23rd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, Aemetis has a consensus rating of “Moderate Buy” and a consensus target price of $12.95.

Aemetis Trading Up 5.3 %

Shares of NASDAQ:AMTX opened at $2.97 on Friday. The stock has a market capitalization of $147.71 million, a PE ratio of -1.31 and a beta of 1.47. Aemetis has a 1 year low of $2.10 and a 1 year high of $7.03. The firm has a fifty day moving average price of $3.27 and a 200 day moving average price of $2.97.

Aemetis (NASDAQ:AMTX) last released its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.47) by $0.09. The company had revenue of $81.44 million for the quarter, compared to the consensus estimate of $77.79 million. During the same quarter last year, the company posted ($0.59) EPS. On average, sell-side analysts forecast that Aemetis will post -2.02 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Aemetis

Several hedge funds and other institutional investors have recently modified their holdings of AMTX. FMR LLC boosted its holdings in Aemetis by 68.2% in the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after purchasing an additional 9,137 shares during the period. Hutchinson Capital Management CA bought a new stake in shares of Aemetis in the second quarter valued at about $70,000. Barclays PLC lifted its stake in shares of Aemetis by 274.6% in the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock valued at $109,000 after buying an additional 34,816 shares during the period. Rhumbline Advisers grew its position in Aemetis by 2,837.1% during the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after buying an additional 50,528 shares in the last quarter. Finally, Wellington Management Group LLP bought a new position in Aemetis during the third quarter valued at about $177,000. Institutional investors and hedge funds own 27.02% of the company’s stock.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.